Shire to buy New Jersey-based NPS Pharma in $5.2B deal
January 11, 2015 at 12:16 PM EST
Less than two months after announcing its U.S. headquarters will be in Massachusetts, Shire Pharmaceuticals (Nasdaq: SHPG) is buying a New Jersey-based maker of gastrointestinal drugs, NPS Pharma for $5...
